These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis. Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878 [TBL] [Abstract][Full Text] [Related]
4. A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis. Yu F; Liu XM; Chen YH; Zhang SQ; Wang K Neurol Sci; 2015 Oct; 36(10):1917-9. PubMed ID: 26032578 [No Abstract] [Full Text] [Related]
6. Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 disease). Sun Y; Almomani R; Breedveld GJ; Santen GW; Aten E; Lefeber DJ; Hoff JI; Brusse E; Verheijen FW; Verdijk RM; Kriek M; Oostra B; Breuning MH; Losekoot M; den Dunnen JT; van de Warrenburg BP; Maat-Kievit AJ Hum Mutat; 2013 May; 34(5):706-13. PubMed ID: 23418007 [TBL] [Abstract][Full Text] [Related]
7. Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene. Hartikainen JM; Ju W; Wisniewski KE; Moroziewicz DN; Kaczmarski AL; McLendon L; Zhong D; Suarez CT; Brown WT; Zhong N Mol Genet Metab; 1999 Jun; 67(2):162-8. PubMed ID: 10356316 [TBL] [Abstract][Full Text] [Related]
8. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients. Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312 [TBL] [Abstract][Full Text] [Related]
9. Late infantile neuronal ceroid lipofuscinosis and dopamine deficiency. Le NM; Parikh S J Child Neurol; 2012 Feb; 27(2):234-7. PubMed ID: 21940688 [TBL] [Abstract][Full Text] [Related]
10. Late infantile neuronal ceroid lipofuscinosis: mutations in the CLN2 gene and clinical course in Spanish patients. Pérez-Poyato MS; Marfa MP; Abizanda IF; Rodriguez-Revenga L; Sánchez VC; González MJ; Puñal JE; Pérez AV; González MM; Bermejo AM; Hernández EM; Rosell MJ; Gort L; Milá M J Child Neurol; 2013 Apr; 28(4):470-8. PubMed ID: 22832778 [TBL] [Abstract][Full Text] [Related]
11. R208X mutation in CLN2 gene associated with reduced cerebrospinal fluid pterins in a girl with classic late infantile neuronal ceroid lipofuscinosis. Barisić N; Logan P; Pikija S; Skarpa D; Blau N Croat Med J; 2003 Aug; 44(4):489-93. PubMed ID: 12950156 [TBL] [Abstract][Full Text] [Related]
12. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes. Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752 [TBL] [Abstract][Full Text] [Related]
13. Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations: Clinical, molecular and biochemical characterization in three sibs. Di Giacopo R; Cianetti L; Caputo V; La Torraca I; Piemonte F; Ciolfi A; Petrucci S; Carta C; Mariotti P; Leuzzi V; Valente EM; D'Amico A; Bentivoglio A; Bertini E; Tartaglia M; Zampino G J Neurol Sci; 2015 Sep; 356(1-2):65-71. PubMed ID: 26143525 [TBL] [Abstract][Full Text] [Related]
14. Clinico-investigative profile of infantile and late-infantile neuronal ceroid lipofuscinoses. Kamate M; Prashanth GP; Hattiholi V Neurol India; 2012; 60(3):316-20. PubMed ID: 22824694 [TBL] [Abstract][Full Text] [Related]
15. [Tripeptidyl peptidase 1 in patients with late infantile neuronal ceroid lipofuscinosis]. Contreras LM; Luengo WD; Zerpa N; Hernández JC; Chávez CJ; Ferrer SG An Pediatr (Barc); 2012 Mar; 76(3):148-52. PubMed ID: 22100780 [TBL] [Abstract][Full Text] [Related]
16. Homozygous missense TPP1 mutation associated with mild late infantile neuronal ceroid lipofuscinosis and the genotype-phenotype correlation. Chen ZR; Liu DT; Meng H; Liu L; Bian WJ; Liu XR; Zhu WW; He Y; Wang J; Tang B; Su T; Yi YH Seizure; 2019 Jul; 69():180-185. PubMed ID: 31059981 [TBL] [Abstract][Full Text] [Related]
17. Prenatal testing for late infantile neuronal ceroid lipofuscinosis. Berry-Kravis E; Sleat DE; Sohar I; Meyer P; Donnelly R; Lobel P Ann Neurol; 2000 Feb; 47(2):254-7. PubMed ID: 10665500 [TBL] [Abstract][Full Text] [Related]
18. Clinical study in Chinese patients with late-infantile form neuronal ceroid lipofuscinoses. Chang X; Huang Y; Meng H; Jiang Y; Wu Y; Xiong H; Wang S; Qin J Brain Dev; 2012 Oct; 34(9):739-45. PubMed ID: 22245569 [TBL] [Abstract][Full Text] [Related]
19. [Tripeptidyl peptidase 1 deficiency in neuronal ceroid lipofuscinosis. A novel mutation]. Bukina AM; Tsvetkova IV; Semiachkina AN; Il'ina ES Vopr Med Khim; 2002; 48(6):594-8. PubMed ID: 12698559 [TBL] [Abstract][Full Text] [Related]
20. A novel CLN2/TPP1 mutation in a Chinese patient with late infantile neuronal ceroid lipofuscinosis. Wang YL; Zeng ZY; Song XW; Hao ZF; Shi YW; Tang B; Chen SQ; Gao MM; Di W; Long YS; Yi YH; Liao WP Neurogenetics; 2011 Feb; 12(1):93-5. PubMed ID: 20820830 [No Abstract] [Full Text] [Related] [Next] [New Search]